Adam D. Judge
- Cancer Research top 1%
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 6
- RNA modifications and cancer 4
- Immunology top 2%
- Immunotherapy and Immune Responses 6
- interferon and immune responses 4
- Immune Response and Inflammation 4
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research 3
- Biomaterials top 5%
-
- Hepatitis B Virus Studies 5
- Co-authors
- Ian MacLachlanKevin McClintockMarjorie RobbinsVandana SoodDianne FangAmy C. H. LeeJanet R. PhelpsLloyd B. Jeffs
- Journals
- The Lancet (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesSouth KoreaSwitzerland
In The Last Decade
Adam D. Judge
24 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.3k
- Molecular Biology 3.8k
- Immunology 1.1k
- Infectious Diseases 483
- Biomaterials 278
Countries citing papers authored by Adam D. Judge
This map shows the geographic impact of Adam D. Judge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Judge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Judge more than expected).
Fields of papers citing papers by Adam D. Judge
This network shows the impact of papers produced by Adam D. Judge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Judge. The network helps show where Adam D. Judge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam D. Judge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2018 | 9 | |
| 3 | 2014 | 77 | |
| 4 | 2013 | 44 | |
| 5 | 2013 | 14 | |
| 6 | 2011 | 17 | |
| 7 | 2010 | 60 | |
| 8 | 2010 | 342 | |
| 9 | 2009 | 273 | |
| 10 | 2009 | 329 | |
| 11 | 2008 | 172 | |
| 12 | 2008 | 217 | |
| 13 | 2008 | 33 | |
| 14 | 2007 | 257 | |
| 15 | 2006 | 181 | |
| 16 | 2005 | 225 | |
| 17 | 2005 | 437 | |
| 18 | Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsbreakdown → | 2005 | 908 |
| 19 | Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNAbreakdown → | 2005 | 957 |
| 20 | 2002 | 8 |
About Adam D. Judge
Adam D. Judge is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 25 papers that have together received 4.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (6 papers), Immunotherapy and Immune Responses (6 papers), Hepatitis B Virus Studies (5 papers), interferon and immune responses (4 papers), RNA modifications and cancer (4 papers), Immune Response and Inflammation (4 papers) and Viral Infections and Outbreaks Research (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (3.8k citations) and Immunology (1.1k citations). Adam D. Judge has collaborated with scholars based in United States, South Korea and Switzerland. Frequent co-authors include Ian MacLachlan, Kevin McClintock, Marjorie Robbins, Vandana Sood, Dianne Fang, Amy C. H. Lee, Janet R. Phelps, Lloyd B. Jeffs, Jonathan Sprent and Iran Tavakoli. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.